| http://www.w3.org/ns/prov#value | - In particular, management`s expectations regarding Lucentis could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company`s ability to obtain or maintain patent or other proprietary intellectual p
|
